Physician profile
Elena Procaccini
NPI 1437970449
$853.66
in general payments reported to CMS, 2019-2025
13 companies · $839 in 2025
The $839 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $14.28 · 2025: $839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $289.75 | 2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $212.24 | 2025 | Freestyle Libre |
| Xeris Pharmaceuticals, INC. | $49.86 | 2025 | Recorlev, Gvoke Hypopen |
| Corcept Therapeutics | $48.65 | 2025 | Korlym |
| Novo Nordisk INC | $43.99 | 2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.20 | 2025 | Jardiance |
| Kyowa Kirin, INC. | $34.54 | 2025 | |
| Recordati_rare_diseases_inc. | $32.02 | 2025 | Isturisa |
| Bayer Healthcare Pharmaceuticals INC. | $30.57 | 2024-2025 | |
| Dexcom, INC. | $25.78 | 2025 | Dexcom G6 Transmitter |
| Averitas Pharma INC. | $17.20 | 2025 | Qutenza |
| Vivus LLC | $16.91 | 2025 | Qsymia |
| Novartis Pharmaceuticals Corporation | $14.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Procaccini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.